RESUMEN
A cross sectional study was carried out in a rural area of Myanmar to identify malaria patients' acceptance of artesunate plus mefloquine drug combination and to determine the cost borne by patients. The majority (88.5%) preferred this new regimen rather than the other ones they had used before; conviction of drug efficacy was the reason given for the preference by most of them. Traveling on foot to rural health centers or a health assistant's residence for getting the drugs was found to be the main route. Average cost incurred by a patient to get the drug was found to be 274.22 Kyats. Among the cost items, drug cost was the highest item that they had used.
Asunto(s)
Antimaláricos/uso terapéutico , Artemisininas , Malaria Falciparum/tratamiento farmacológico , Mefloquina/uso terapéutico , Cooperación del Paciente , Sesquiterpenos/uso terapéutico , Adolescente , Adulto , Anciano , Antimaláricos/economía , Artesunato , Estudios Transversales , Combinación de Medicamentos , Femenino , Costos de la Atención en Salud , Humanos , Malaria Falciparum/economía , Malaria Falciparum/epidemiología , Masculino , Mefloquina/economía , Persona de Mediana Edad , Mianmar/epidemiología , Población Rural , Sesquiterpenos/economíaRESUMEN
Twenty-two hospitalized HIV seropositive patients were studied prospectively between July 1991 and January 1992. The majority of the patients were intravenous drug users (IVDUs). Their age ranged from 20 to 38 years with a male preponderance of 12 to 1. Anemia, lymphopenia and thrombocytopenia were observed in 100%, 36% and 41%, respectively. The common pathogens like malaria parasites, Mycobacterium tuberculosis, Entamoeba histolytica, Streptococcus and Salmonella were isolated/identified rather than opportunistic organisms.